Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine

Clinical reports and animal experiments indicate that both cocaine administration and cocaine withdrawal increase anxiety. We investigated the ability of a number of putative anxiolytic agents to alleviate these anxiety states using the elevated plus-maze. Rats in the cocaine condition received eith...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Behavioural pharmacology 2002-11, Vol.13 (7), p.511-523
Hauptverfasser: Paine, T.A, Jackman, S.L, Olmstead, M.C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 523
container_issue 7
container_start_page 511
container_title Behavioural pharmacology
container_volume 13
creator Paine, T.A
Jackman, S.L
Olmstead, M.C
description Clinical reports and animal experiments indicate that both cocaine administration and cocaine withdrawal increase anxiety. We investigated the ability of a number of putative anxiolytic agents to alleviate these anxiety states using the elevated plus-maze. Rats in the cocaine condition received either saline or cocaine (20 mg/kg) 40 min prior to testing; those in the withdrawal condition were tested 48 h following a chronic treatment regime (saline or cocaine 20 mg/kg per day for 14 days). Prior to testing, animals received a benzodiazepine (1.0 or 2.0 mg/kg diazepam), a serotonergic agonist (0.5 or 1.0 mg/kg buspirone), an antihistamine (50 mg/kg dimenhydrinate or 27 mg/kg diphenhydramine) or a saline injection. All drugs were administered intraperitoneally. Cocaine administration and cocaine withdrawal reduced the percentage time spent on and the number of entries into the open arms. Diazepam dose-dependently alleviated cocaine withdrawal-induced anxiety and non-significantly attenuated cocaine-induced anxiety. Buspirone, dimenhydrinate and diphenhydramine did not consistently alleviate the anxiety caused by either cocaine pre-treatment regime; in the saline conditions, however, each of these treatments was anxiogenic. In summary, benzodiazepines alleviated cocaine-induced anxiety, while future research on the ability of serotonergic and antihistaminergic drugs to alleviate these anxiety states is warranted.
doi_str_mv 10.1097/00008877-200211000-00001
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00008877_200211000_00001</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>12409990</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3561-f7c18ca837a31f2d18efcc2ddc215de1bf0696ed4ba202f0ac63a31d05e61b2c3</originalsourceid><addsrcrecordid>eNp1UctOwzAQtBCIlsIvoHxAA17nYYcbqnhJlbjAOXLsjWJInMhJgPD1uKTAib2MdnZmDrOEBEAvgGb8kvoRgvOQUcoA_BbuKDggS4h5FCYizg7JkmZJEgoBdEFO-v5lZ4o5PyYLYDHNsowuSblplTQWQ2P1qFAH0n4YHKarQNY1vhk5mNYGxRRoIz-xk806KMYhsO3gse-May2u_bFBW03aGSsHDFrnma6aKdn4-FNyVMq6x7M9rsjz7c3T5j7cPt49bK63oYqSFMKSKxBKiojLCEqmQWCpFNNaMUg0QlHSNEtRx4VklJVUqjTySk0TTKFgKloRMecq1_a9wzLvnGmkm3Kg-a66_Ke6_Le6bwq89Xy2dmPRoP4z7rvygngWvLf1gK5_rcd3dHmFsh6q_L-XRF8BCXuU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine</title><source>MEDLINE</source><source>Journals@Ovid Ovid Autoload</source><creator>Paine, T.A ; Jackman, S.L ; Olmstead, M.C</creator><creatorcontrib>Paine, T.A ; Jackman, S.L ; Olmstead, M.C</creatorcontrib><description>Clinical reports and animal experiments indicate that both cocaine administration and cocaine withdrawal increase anxiety. We investigated the ability of a number of putative anxiolytic agents to alleviate these anxiety states using the elevated plus-maze. Rats in the cocaine condition received either saline or cocaine (20 mg/kg) 40 min prior to testing; those in the withdrawal condition were tested 48 h following a chronic treatment regime (saline or cocaine 20 mg/kg per day for 14 days). Prior to testing, animals received a benzodiazepine (1.0 or 2.0 mg/kg diazepam), a serotonergic agonist (0.5 or 1.0 mg/kg buspirone), an antihistamine (50 mg/kg dimenhydrinate or 27 mg/kg diphenhydramine) or a saline injection. All drugs were administered intraperitoneally. Cocaine administration and cocaine withdrawal reduced the percentage time spent on and the number of entries into the open arms. Diazepam dose-dependently alleviated cocaine withdrawal-induced anxiety and non-significantly attenuated cocaine-induced anxiety. Buspirone, dimenhydrinate and diphenhydramine did not consistently alleviate the anxiety caused by either cocaine pre-treatment regime; in the saline conditions, however, each of these treatments was anxiogenic. In summary, benzodiazepines alleviated cocaine-induced anxiety, while future research on the ability of serotonergic and antihistaminergic drugs to alleviate these anxiety states is warranted.</description><identifier>ISSN: 0955-8810</identifier><identifier>EISSN: 1473-5849</identifier><identifier>DOI: 10.1097/00008877-200211000-00001</identifier><identifier>PMID: 12409990</identifier><language>eng</language><publisher>England: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Animals ; Anti-Anxiety Agents - pharmacology ; Anxiety - chemically induced ; Anxiety - prevention &amp; control ; Anxiety - psychology ; Buspirone - pharmacology ; Cocaine - adverse effects ; Conflict (Psychology) ; Diazepam - pharmacology ; Dimenhydrinate - pharmacology ; Diphenhydramine - pharmacology ; Dose-Response Relationship, Drug ; Exploratory Behavior - drug effects ; Injections, Intraperitoneal ; Male ; Maze Learning - drug effects ; Rats ; Rats, Long-Evans ; Substance Withdrawal Syndrome - prevention &amp; control ; Substance Withdrawal Syndrome - psychology</subject><ispartof>Behavioural pharmacology, 2002-11, Vol.13 (7), p.511-523</ispartof><rights>2002 Lippincott Williams &amp; Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3561-f7c18ca837a31f2d18efcc2ddc215de1bf0696ed4ba202f0ac63a31d05e61b2c3</citedby><cites>FETCH-LOGICAL-c3561-f7c18ca837a31f2d18efcc2ddc215de1bf0696ed4ba202f0ac63a31d05e61b2c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12409990$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Paine, T.A</creatorcontrib><creatorcontrib>Jackman, S.L</creatorcontrib><creatorcontrib>Olmstead, M.C</creatorcontrib><title>Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine</title><title>Behavioural pharmacology</title><addtitle>Behav Pharmacol</addtitle><description>Clinical reports and animal experiments indicate that both cocaine administration and cocaine withdrawal increase anxiety. We investigated the ability of a number of putative anxiolytic agents to alleviate these anxiety states using the elevated plus-maze. Rats in the cocaine condition received either saline or cocaine (20 mg/kg) 40 min prior to testing; those in the withdrawal condition were tested 48 h following a chronic treatment regime (saline or cocaine 20 mg/kg per day for 14 days). Prior to testing, animals received a benzodiazepine (1.0 or 2.0 mg/kg diazepam), a serotonergic agonist (0.5 or 1.0 mg/kg buspirone), an antihistamine (50 mg/kg dimenhydrinate or 27 mg/kg diphenhydramine) or a saline injection. All drugs were administered intraperitoneally. Cocaine administration and cocaine withdrawal reduced the percentage time spent on and the number of entries into the open arms. Diazepam dose-dependently alleviated cocaine withdrawal-induced anxiety and non-significantly attenuated cocaine-induced anxiety. Buspirone, dimenhydrinate and diphenhydramine did not consistently alleviate the anxiety caused by either cocaine pre-treatment regime; in the saline conditions, however, each of these treatments was anxiogenic. In summary, benzodiazepines alleviated cocaine-induced anxiety, while future research on the ability of serotonergic and antihistaminergic drugs to alleviate these anxiety states is warranted.</description><subject>Animals</subject><subject>Anti-Anxiety Agents - pharmacology</subject><subject>Anxiety - chemically induced</subject><subject>Anxiety - prevention &amp; control</subject><subject>Anxiety - psychology</subject><subject>Buspirone - pharmacology</subject><subject>Cocaine - adverse effects</subject><subject>Conflict (Psychology)</subject><subject>Diazepam - pharmacology</subject><subject>Dimenhydrinate - pharmacology</subject><subject>Diphenhydramine - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Exploratory Behavior - drug effects</subject><subject>Injections, Intraperitoneal</subject><subject>Male</subject><subject>Maze Learning - drug effects</subject><subject>Rats</subject><subject>Rats, Long-Evans</subject><subject>Substance Withdrawal Syndrome - prevention &amp; control</subject><subject>Substance Withdrawal Syndrome - psychology</subject><issn>0955-8810</issn><issn>1473-5849</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UctOwzAQtBCIlsIvoHxAA17nYYcbqnhJlbjAOXLsjWJInMhJgPD1uKTAib2MdnZmDrOEBEAvgGb8kvoRgvOQUcoA_BbuKDggS4h5FCYizg7JkmZJEgoBdEFO-v5lZ4o5PyYLYDHNsowuSblplTQWQ2P1qFAH0n4YHKarQNY1vhk5mNYGxRRoIz-xk806KMYhsO3gse-May2u_bFBW03aGSsHDFrnma6aKdn4-FNyVMq6x7M9rsjz7c3T5j7cPt49bK63oYqSFMKSKxBKiojLCEqmQWCpFNNaMUg0QlHSNEtRx4VklJVUqjTySk0TTKFgKloRMecq1_a9wzLvnGmkm3Kg-a66_Ke6_Le6bwq89Xy2dmPRoP4z7rvygngWvLf1gK5_rcd3dHmFsh6q_L-XRF8BCXuU</recordid><startdate>200211</startdate><enddate>200211</enddate><creator>Paine, T.A</creator><creator>Jackman, S.L</creator><creator>Olmstead, M.C</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200211</creationdate><title>Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine</title><author>Paine, T.A ; Jackman, S.L ; Olmstead, M.C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3561-f7c18ca837a31f2d18efcc2ddc215de1bf0696ed4ba202f0ac63a31d05e61b2c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Anti-Anxiety Agents - pharmacology</topic><topic>Anxiety - chemically induced</topic><topic>Anxiety - prevention &amp; control</topic><topic>Anxiety - psychology</topic><topic>Buspirone - pharmacology</topic><topic>Cocaine - adverse effects</topic><topic>Conflict (Psychology)</topic><topic>Diazepam - pharmacology</topic><topic>Dimenhydrinate - pharmacology</topic><topic>Diphenhydramine - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Exploratory Behavior - drug effects</topic><topic>Injections, Intraperitoneal</topic><topic>Male</topic><topic>Maze Learning - drug effects</topic><topic>Rats</topic><topic>Rats, Long-Evans</topic><topic>Substance Withdrawal Syndrome - prevention &amp; control</topic><topic>Substance Withdrawal Syndrome - psychology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Paine, T.A</creatorcontrib><creatorcontrib>Jackman, S.L</creatorcontrib><creatorcontrib>Olmstead, M.C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Behavioural pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Paine, T.A</au><au>Jackman, S.L</au><au>Olmstead, M.C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine</atitle><jtitle>Behavioural pharmacology</jtitle><addtitle>Behav Pharmacol</addtitle><date>2002-11</date><risdate>2002</risdate><volume>13</volume><issue>7</issue><spage>511</spage><epage>523</epage><pages>511-523</pages><issn>0955-8810</issn><eissn>1473-5849</eissn><abstract>Clinical reports and animal experiments indicate that both cocaine administration and cocaine withdrawal increase anxiety. We investigated the ability of a number of putative anxiolytic agents to alleviate these anxiety states using the elevated plus-maze. Rats in the cocaine condition received either saline or cocaine (20 mg/kg) 40 min prior to testing; those in the withdrawal condition were tested 48 h following a chronic treatment regime (saline or cocaine 20 mg/kg per day for 14 days). Prior to testing, animals received a benzodiazepine (1.0 or 2.0 mg/kg diazepam), a serotonergic agonist (0.5 or 1.0 mg/kg buspirone), an antihistamine (50 mg/kg dimenhydrinate or 27 mg/kg diphenhydramine) or a saline injection. All drugs were administered intraperitoneally. Cocaine administration and cocaine withdrawal reduced the percentage time spent on and the number of entries into the open arms. Diazepam dose-dependently alleviated cocaine withdrawal-induced anxiety and non-significantly attenuated cocaine-induced anxiety. Buspirone, dimenhydrinate and diphenhydramine did not consistently alleviate the anxiety caused by either cocaine pre-treatment regime; in the saline conditions, however, each of these treatments was anxiogenic. In summary, benzodiazepines alleviated cocaine-induced anxiety, while future research on the ability of serotonergic and antihistaminergic drugs to alleviate these anxiety states is warranted.</abstract><cop>England</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>12409990</pmid><doi>10.1097/00008877-200211000-00001</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0955-8810
ispartof Behavioural pharmacology, 2002-11, Vol.13 (7), p.511-523
issn 0955-8810
1473-5849
language eng
recordid cdi_crossref_primary_10_1097_00008877_200211000_00001
source MEDLINE; Journals@Ovid Ovid Autoload
subjects Animals
Anti-Anxiety Agents - pharmacology
Anxiety - chemically induced
Anxiety - prevention & control
Anxiety - psychology
Buspirone - pharmacology
Cocaine - adverse effects
Conflict (Psychology)
Diazepam - pharmacology
Dimenhydrinate - pharmacology
Diphenhydramine - pharmacology
Dose-Response Relationship, Drug
Exploratory Behavior - drug effects
Injections, Intraperitoneal
Male
Maze Learning - drug effects
Rats
Rats, Long-Evans
Substance Withdrawal Syndrome - prevention & control
Substance Withdrawal Syndrome - psychology
title Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T06%3A21%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cocaine-induced%20anxiety:%20alleviation%20by%20diazepam,%20but%20not%20buspirone,%20dimenhydrinate%20or%20diphenhydramine&rft.jtitle=Behavioural%20pharmacology&rft.au=Paine,%20T.A&rft.date=2002-11&rft.volume=13&rft.issue=7&rft.spage=511&rft.epage=523&rft.pages=511-523&rft.issn=0955-8810&rft.eissn=1473-5849&rft_id=info:doi/10.1097/00008877-200211000-00001&rft_dat=%3Cpubmed_cross%3E12409990%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12409990&rfr_iscdi=true